Search research articles
Contact Us
Filters
Showing results (111-120 of 133) with videos related to
Page
of 14
Sort By:
Research Square
|
February 26, 2024
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes
Varadha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, et al.
Cell Reports. Medicine
|
November 22, 2023
Aurora A kinase inhibition induces accumulation of SCLC tumor cells in mitosis with restored interferon signaling to increase response to PD-L1
Yixiang Li, Navin R Mahadevan, Leslie Duplaquet, et al.
Nature Communications
|
August 8, 2024
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes
Varadha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, et al.
Biorxiv : the Preprint Server for Biology
|
July 10, 2023
A cellular and spatial atlas of <i>TP53</i> -associated tissue remodeling in lung adenocarcinoma
William Zhao, Benjamin Kepecs, Navin R Mahadevan, et al.
Cancer Research
|
September 6, 2022
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer
Ryohei Yoshida, Maria Saigi, Tetsuo Tani, et al.
Cell Reports. Medicine
|
June 21, 2025
Immune targeting of triple-negative breast cancer through a clinically actionable STING agonist-CAR T cell platform
Yuqing Zhang, Zehua Li, Jessica Ritter, et al.
Nature Communications
|
September 24, 2022
Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitors
Yoshihisa Kobayashi, Geoffrey R Oxnard, Elizabeth F Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2024
Detecting Small Cell Transformation in Patients with Advanced EGFR Mutant Lung Adenocarcinoma through Epigenomic cfDNA Profiling
Talal El Zarif, Catherine B Meador, Xintao Qiu, et al.
Cancer Discovery
|
January 16, 2024
TREX1 Inactivation Unleashes Cancer Cell STING-Interferon Signaling and Promotes Antitumor Immunity
Tetsuo Tani, Haritha Mathsyaraja, Marco Campisi, et al.
Nature Communications
|
May 2, 2026
PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancer
Zehua Li, Cong Fu, Kartik Sehgal, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 133) with videos related to
Sort By:
Page
of 14
Research Square
|
February 26, 2024
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes
Varadha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, et al.
Cell Reports. Medicine
|
November 22, 2023
Aurora A kinase inhibition induces accumulation of SCLC tumor cells in mitosis with restored interferon signaling to increase response to PD-L1
Yixiang Li, Navin R Mahadevan, Leslie Duplaquet, et al.
Nature Communications
|
August 8, 2024
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes
Varadha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, et al.
Biorxiv : the Preprint Server for Biology
|
July 10, 2023
A cellular and spatial atlas of <i>TP53</i> -associated tissue remodeling in lung adenocarcinoma
William Zhao, Benjamin Kepecs, Navin R Mahadevan, et al.
Cancer Research
|
September 6, 2022
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer
Ryohei Yoshida, Maria Saigi, Tetsuo Tani, et al.
Cell Reports. Medicine
|
June 21, 2025
Immune targeting of triple-negative breast cancer through a clinically actionable STING agonist-CAR T cell platform
Yuqing Zhang, Zehua Li, Jessica Ritter, et al.
Nature Communications
|
September 24, 2022
Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitors
Yoshihisa Kobayashi, Geoffrey R Oxnard, Elizabeth F Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2024
Detecting Small Cell Transformation in Patients with Advanced EGFR Mutant Lung Adenocarcinoma through Epigenomic cfDNA Profiling
Talal El Zarif, Catherine B Meador, Xintao Qiu, et al.
Cancer Discovery
|
January 16, 2024
TREX1 Inactivation Unleashes Cancer Cell STING-Interferon Signaling and Promotes Antitumor Immunity
Tetsuo Tani, Haritha Mathsyaraja, Marco Campisi, et al.
Nature Communications
|
May 2, 2026
PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancer
Zehua Li, Cong Fu, Kartik Sehgal, et al.
Page
of 14